AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

10h ago, source: Zacks.com on MSN

AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

AnaptysBio Inc (ANAB) Shares Plummet Below 1-Year High

12d ago, source: newsheater

The stock of AnaptysBio Inc (NASDAQ: ANAB) has decreased by -7.64 when compared to last closing price of 21.47.Despite this, the company has seen a loss of -19.81% in its stock price over the last ...

Leerink Partners Initiates Coverage of AnaptysBio (ANAB) with Outperform Recommendation

14d ago, source: Fintel on MSN

Fintel reports that on April 16, 2024, Leerink Partners initiated coverage of AnaptysBio (NasdaqGS:ANAB) with a Outperform ...

Pfizer’s Beqvez taking on Hemgenix with FDA nod in hemophilia B

5d ago, source: BioWorld

Others exploring the mechanism include Anaptysbio Inc., Eli Lilly and Co., and Johnson & Johnson. In March 2024, BioWorld reported on 261 updates on phase I-III clinical trials, showing a 10.6% ...

Actym Therapeutics Appoints Thomas Smart as CEO

7d ago, source:

Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as ...

Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)

12d ago, source: The Wall Street Transcript

It’s been a few years since you last spoke with The Wall Street Transcript. Can you provide a refresher on the history and overview of the company? Mr. Steel: Sure. So we started Equillium back in ...

Actym Therapeutics Inc.: Actym Therapeutics Appoints Thomas Smart as CEO

7d ago, source: Finanznachrichten

His prior leadership roles include serving as CEO and Board Chair of AnaptysBio (NASDAQ: ANAB), Chief Business Officer of XOMA (NASDAQ: XOMA), and various positions at Genetics Institute (now Pfizer), ...